Biocatalytic Polymer Skin Adhesives

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$494,666.00
Award Year:
2001
Program:
STTR
Phase:
Phase II
Contract:
DAAD19-02-C-0010
Award Id:
55389
Agency Tracking Number:
A2-0029
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
3636 Boulevard of the Allies, Suite B-17, Pittsburgh, PA, 15213
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
041791695
Principal Investigator:
KeithLeJeune
(412) 209-7298
Business Contact:
KeithLeJeune
(412) 209-7298
Research Institute:
MIDWEST RESEARCH INSTITUTE
Jeanette Tombaugh
425 Volker Boulevard
Kansas City, MO, 64110
(816) 753-7600
Domestic nonprofit research organization
Abstract
This Phase II STTR proposal describes the development of a prototype enzyme-containing adhesive capable of attaching biocatalytic activity directly to skin. The adhesive, when containing organophosphorus-hydrolyzing enzymes, shall serve to protectunderlying skin from otherwise toxic applications of nerve agents and pesticides. Agentase, a recognized world leader in developing polymer-based carriers for enzyme catalysis, in collaboration with the Midwest Research Institute, shall demonstrate thefeasibility of providing personal protection from hazardous chemicals to individuals via enzyme-based skin adhesives.Having successfully demonstrated the viability of synthesizing biocatalytic adhesives with significant enzyme activity and excellent physical properties during Phase I, Phase II activity is directed at developing a prototype adhesive for protection againstOPs. More specifically, proposed work includes optimization of the processes for applying adhesives in a reproducible and uniform fashion, enhancing their capacity for decontamination, and ensuring polymer as well as polymerization compatibility with skintissues. Phase II research shall also provide a clear demonstration that enzyme-containing skin adhesives can be effectively used to protect a small animal model from the debilitating effects of OP exposures. Successful completion of the aims describedin this Phase II STTR proposal will provide a novel biopolymer skin adhesive for protection against organophosphorus contamination from nerve agents and pesticides. The addition of active biomolecules, such as enzymes, to a skin-compatible biopolymeradhesive has great potential in facilitated wound healing.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government